Danka Radosavljevic
CIK: 0002149737
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ETON
Eton Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Radosavljevic Danka
Radosavljevic Danka (SEC CIK 0002149737) files insider reports with the SEC as Chief Operating Officer of Eton Pharmaceuticals, Inc. (ETON).
Signal8 holds 1 ownership filing by Radosavljevic Danka, a Form 3, filed on Aug 12, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Radosavljevic Danka's filings is in DEERPARK, IL.
Other insiders filing for Eton Pharmaceuticals, Inc. (ETON)
- Krempa David, Chief Business Officer
- MAIER PAUL V, Director
- BRYNJELSEN SEAN, President & CEO
- CASAMENTO CHARLES J, Director
- Matthews Judith M., Chief Financial Officer
- Erdogan-Trinkaus Ipek, Chief Commercial Officer